# Open-Label, Safety Study of Lofexidine

> **NCT02363998** · PHASE3 · COMPLETED · sponsor: **USWM, LLC (dba US WorldMeds)** · enrollment: 286 (actual)

## Conditions studied

- Opioid Withdrawal

## Interventions

- **DRUG:** Lofexidine

## Key facts

- **NCT ID:** NCT02363998
- **Lead sponsor:** USWM, LLC (dba US WorldMeds)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-09
- **Final completion:** 2015-10
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2022-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02363998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02363998, "Open-Label, Safety Study of Lofexidine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02363998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*